Diabetes News

Semaglutide conferred greater reductions in HbA1c and body weight among adults with type 2 diabetes than other GLP-1 receptor agonists, according to findings from a systematic review and meta-analysis.

A new generation of obesity drugs is changing the treatment landscape for patients and providers, with options that can lead to weight loss unheard of just a few years ago.

Last month, WHO’s International Agency for Research on Cancer declared aspartame — a popular artificial sweetener that is used in products like soft drinks, chewing gum and ice cream — a potential carcinogen.

Blood tests showed that canagliflozin plus standard care lowered biomarkers levels associated with chronic kidney disease and CVD events in patients with diabetes and albuminuria vs. placebo, researchers reported.

A 10-year intensive lifestyle intervention designed for weight loss in those with type 2 diabetes and overweight/obesity was tied to significantly higher employment levels compared with diabetes education alone, according to researchers.

Adults with diabetes who smoke or exercise less than once per week are among those at higher risk for a lower limb amputation, but adults with obesity may have a lower risk for amputations, according to study data.

HOUSTON — SGLT2 inhibitors should be the first choice of therapy for adults with type 2 diabetes and heart failure, according to two speakers at the Association of Diabetes Care and Education Specialists annual meeting.

Amazon Pharmacy is launching new technology that will automatically apply manufacturer coupons for customers purchasing insulin and diabetes care products, according to a press release.

A wellness-inspired 4-day masterclass covering all aspects of women’s cardiometabolic health offers attendees a mix of multidisciplinary education, networking activities and professional development, as well as ways to relax and recharge.

HOUSTON — People with type 1 diabetes who use cannabis and present at a hospital with diabetic ketoacidosis symptoms may have hyperglycemic ketosis related to cannabis hyperemesis syndrome, according to a speaker.